Utilization of The Chronic Disease Management Program During The Covid-19 Pandemic

  • Andi Nur Azizah Bagian Administrasi Kebijakan Kesehatan, Universitas Islam Negeri Alauddin, Makassar
    (ID)
  • Sitti Raodhah Bagian Administrasi Kebijakan Kesehatan, Universitas Islam Negeri Alauddin, Makassar
    (ID)
  • Surahmawati Surahmawati Bagian Administrasi Kebijakan Kesehatan, Universitas Islam Negeri Alauddin, Makassar
    (ID)
  • Syamsul Alam Bagian Gizi, Universitas Islam Negeri Alauddin, Makassar
    (ID)

Abstract

The increasing number of chronic diseases such as hypertension and diabetes mellitus has made the government through Health BPJS promote and prevent through chronic disease management programs (Prolanis). The occurrence of the Covid-19 pandemic has changed all aspects of life including Prolanis activities. This study aims to determine the use of the chronic disease management program (Prolanis) during the Covid-19 pandemic at the Tamamaung public health center, Makassar City with this type of qualitative research. Determination of informants in this study using a purposive sampling technique. The informants in this study consisted of Prolanis management officers, Prolanis participants who suffered from hypertension, and type 2 diabetes mellitus. Data was collected through in-depth interviews with informants. The results of the study explained that the use of Prolanis during the Covid-19 pandemic still received support from families by reminding each other to maintain health. Health workers continue to serve participants as usual for medical examinations and routine monthly administration of drugs unless education and gymnastics are temporarily prevented The need for health services, where participants feel they still need exercise and education activities. However, due to the Covid-19 pandemic, participants can only carry out health checks and take routine medicine every month. It is recommended that health workers continue to increase their role as educators by providing education to Prolanis participants both during the Covid-19 pandemic period and after the pandemic ends and emphasizing the importance of joining Prolanis. 

Downloads

Download data is not yet available.

References

Abdullah, A., Sjattar, E. L., & Kadir, A. R. (2017). Faktor Penyebab Terjadinya Penurunan Jumlah Kunjungan Peserta Program Pengelolaan Penyakit Kronis (Prolanis) di Puskesmas Minasa Upa Kota Makassar. Jurnal Ilmiah Kesehatan Diagnosis, 11(4), 382-387.

Agustina, E. (2017). Hubungan Dukungan Keluarga Dengan Keaktifan Lansia dalam Mengikuti Kegiatan Posyandu Lansia. Ilmu Keperawatan, 4, 9–15.

Ahmalia, R., & Desriyenti. (2018). Hubungan Pengetahuan dan Dukungan Keluarga Dengan Tingkat Kepatuhan Mengikuti Program Pengelolaan Penyakit Kronis (Prolanis) di Wilayah KerjaPuskesmas Kampung Dalam Kabupaten Padang Pariaman Tahun 2018 Knowledge Relationship and Family Support With Leve. Jurnal Kesehatan Prima Nusantara Bukit Tinggi, 9(2), 116–123.

Arifa, A. F. C. (2018). Pengaruh Informasi Pelayanan Prolanis Dan Kesesuaian Waktu Terhadap Pemanfaatan Prolanis Di Pusat Layanan Kesehatan Unair. Jurnal Administrasi Kesehatan Indonesia, 6(2), 95.

BPJS Kesehatan. (2014). Panduan praktis Prolanis (Program pengelolaan penyakit kronis). BPJS Kesehatan.

Gustianto, V., Sadik, D., & Gusti, Y. T. (2020). Hubungan Dukungan Keluarga Dalam Program Prolanis Dengan Kepatuhan Minum Obat Pasien Diabetes Melitus Tipe 2 Di Puskesmas Rawat Inap Banjarsari Kota Metro Tahun 2019. Jurnal Ilmu Kesehatan Indonesia, 1(1), 1–11.

Hutagalung, P. G. J., Ginting, R., & Manalu, P. (2020). Faktor-faktor yang mempengaruhi pemanfaatan Program Pengelolaan Penyakit Kronis (Prolanis) pada lansia di Puskesmas Darussalam Medan. Jurnal Prima Medika Sains, 02(1), 24–31.

IDF. (2019). IDF Diabetes Atlas Ninth edition 2019. In International Diabetes Federation. http://www.idf.org/about-diabetes/facts-figures

Kemenkes RI. (2020). Situasi Terkini Perkembangan Coronavirus Disease (COVID-19) 15 Juli 2020 di indonesia. Kementrian Kesehatan Republik Indonesia. https://covid19.kemkes.go.id/situasi-infeksi-emerging/info-corona-virus/situasi-terkini-perkembangan-coronavirus-disease-covid-19-16-juli-2020/#.XxJa4CgzbDc

Purnamasari, S. M., & Prameswari, G. N. (2020). Pemanfaatan Program Pengelolaan Penyakit Kronis di Puskesmas. Higeia Journal Of Public Health Research And Development, 4(2), 256–266.

Puspita, E., Oktaviarini, E., Dyah, Y., & Santik, P. (2017). Peran keluarga dan petugas kesehatan dalam kepatuhan pengobatan penderita hipertensi di Puskesmas Gungpati Kota Semarang. Jurnal Kesehatan Masyarakat Indonesia, 12(2), 25–32.

Riskesdas. (2018). Hasil Utama Riset Kesehata Dasar (RISKESDAS). Journal of Physics A: Mathematical and Theoretical, 44(8), 1–200.

Setiyaningsih, R., & Ningsih, S. (2019). Pengaruh Motivasi, Dukungan Keluarga Dan Peran Kader Terhadap Perilaku Pengendalian Hipertensi. Indonesian Journal On Medical Science, 6(1), 79–85.

Setyarini, R., Arso, S. P., & Suparwati, A. (2018). Faktor – Faktor Yang Berhubungan Dengan Pemanfaatan Ulang Puskesmas Santun Lansia Karangdoro Kota Semarang Tahun 2016. Jurnal Kesehatan Masyarakat, 51(1), 51.

Suyadi, B., & Haizurrachamn. (2017). Pengaruh Petugas Kesehatan, Keluarga, Lingkungan Kerja, Motivasi Terhadap Gaya Hidup Penderita Hipertensi. Jurnal Ilmiah Kesehatan, 16, 42–51.

Tiksnadi, B. B., Sylviana, N., Cahyadi, A. I., & Undarsa, A. C. (2020). Olahraga Rutin Untuk Meningkatkan Imunitas Pasien Hipertensi Selama Masa Pandemi COVID-19. Indonesian Journal of Cardiology, 41(2), 113-9.

WHO. (2018). Noncommunicable Disease Country Profiles 2018. In World health organization. https://doi.org/10.1002/9781119097136.part5

WHO. (2020). Coronavirus disease (COVID-19) Situation Report – 177 Data. World Health Organization, 14(6), e01218. https://doi.org/10.1213/xaa.0000000000001218

Published
2021-01-18
How to Cite
Azizah, A. N., Raodhah, S., Surahmawati, S., & Alam, S. (2021). Utilization of The Chronic Disease Management Program During The Covid-19 Pandemic. Diversity: Disease Preventive of Research Integrity, 1(1), 21-29. https://doi.org/10.24252/diversity.v1i1.18724
Section
Volume 1, Issue 1, 2020
Abstract viewed = 672 times